Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|October 31, 2022
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patientsAntonella Galiano, Stefania Schiavon, Mariateresa Nardi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2023
Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps' number in clinical management and colorectal cancer riskSilvia Negro, Quoc Riccardo Bao, Marco Scarpa, et al.Cancer Treatment Reviews|July 24, 2026
Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysisAndrea Pretta, Riccardo Giampieri, Andrea Bottelli, et al.British Journal of Cancer|June 6, 2022
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?Roberto Moretto, Andrew Elliott, Daniele Rossini, et al.Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint InhibitorsClaire Gallois, Matteo Landi, Julien Taieb, et al.Frontiers in Oncology|July 30, 2019
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With RegorafenibAlessio Amatu, Marta Schirripa, Federica Tosi, et al.The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.Eclinicalmedicine|January 7, 2026
Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort studySilvia Negro, Francesco Celotto, Francesca Schiavi, et al.British Journal of Cancer|September 3, 2019
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancerFotios Loupakis, Paola Biason, Alessandra Anna Prete, et al.Pageof 4